TC BioPharm (Holdings) plc - Warrants (08/02/2027) EBIT

The latest EBIT for TCBPW is $-24M as of June 2024. That compares with $-2.1M in the prior-year period — down 1054.2% year over year. That is above the sector sector average of $-69M. Investors often review this figure alongside TC BioPharm (Holdings) plc - Warrants (08/02/2027)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, TCBPW's EBIT moved from $-2.1M to $-24M — a 1054.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in TC BioPharm (Holdings) plc - Warrants (08/02/2027)'s operating scale or balance-sheet position.

Against its sector companies, TCBPW currently prints $-24M for EBIT, while the sector average sits near $-69M. That is roughly 64.5% above the sector mean. Large gaps often invite a closer look at TC BioPharm (Holdings) plc - Warrants (08/02/2027)'s growth, margins, and balance sheet.

A EBIT figure of $-24M for TCBPW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-69M. Explore the charts below for those layers of context.

After noting TCBPW's EBIT ($-24M), review year-over-year change from $-2.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.